drugset / Trial / NCT06977750

Clinical Study on the Effectiveness and Safety of Succinylated Gelatin Electrolyte Sodium Acetate Injection

NCT06977750 ↗

RandomizedParallel-groupDouble-blindTreatment

Summary

The succinylated gelatin electrolyte sodium acetate injection (specification: 500 mL: 20 g) developed and produced by Nanjing Chia-tai Tianqing Pharmaceutical. is used as the experimental drug, and the succinylated gelatin electrolyte sodium acetate injection (trade name: Jialeban) produced and licensed by Braun Medical (Suzhou) Co., Ltd ®; Specification: 500 mL: 20 g) is used as a control drug to evaluate the clinical equivalence of two formulations in patients planning elective surgery by comparing the changes in stroke volume (SV) between 5 minutes after completion of ANH and immediately before the start of ANH.

Timeline

Start
2025-04-27
Primary completion
2025-10-31
Completion
2025-12-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Jialeban Unknown — —

Indications

No indication recorded.